Type 2 Diabetes Mellitus Therapeutics Market Trends Analysis and Forecasts to 2021

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Market Size, Share,

Global Trends, Company Profiles, Demand, Insights, Analysis, Research,

Report, Opportunities, Segmentation and Forecast To 2014 – 2021

Type 2 Diabetes mellitus (T2DM) is a disease marked by lack of insulin, insulin resistance, and

high blood sugar. This disease has long-term damage that results in failure and dysfunction of

multiple organs including blood vessels, heart, nerves, kidneys, and eyes. About 85% of

diabetics have the chances of getting T2DM. The rising cases of diabetes can be attributed to

reduced physical activity and consumption of high-calorie diets. A healthy diet and lifestyle

change can improve the chances of recovering from T2DM.

The T2DM therapeutics market in Asia Pacific has evolved in the last decade. It has brought

about promising treatments such as SGLT-2 inhibitor, GLP-1 receptor agonist, DPP-4 inhibitor,

sulfonylureas, biguanide, and other insulin therapies. But alternative products offering better

glycemic control hamper market growth. GIP (Gastric inhibitory polypeptide) is impaired during

type 2 diabetes, but GLP-1 is preserved proving beneficial to therapy.

Sulfonylureas help your body secrete more insulin. Examples of medication in this class of

medicines are glipizide and glyburide. Meglitinides work similarly to sulfonylureas but are

faster-acting agents. Examples of medication include nateglinide and repaglinide. DPP-4

inhibitors reduce blood sugar levels and negate the possibility of weight gain. Examples include

saxagliptin and sitagliptin.

For further information on this report, please visit http://www.radiantinsights.com/research/type-2-diabetes-mellitus-therapeutics-in-asiapacific-markets

GLP-1 receptor agonists lower blood sugar level and slow digestion. Examples of this

medication are liraglutide and exenatide. SGLT-2 inhibitors are newest drugs in the market

which prevents sugar to be absorbed into the blood and excretes...